These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22741575)

  • 1. Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.
    Guo YF; Wang XB; Tian XY; Li Y; Li B; Huang Q; Zhang M; Li Z
    World J Surg Oncol; 2012 Jun; 10():128. PubMed ID: 22741575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
    Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
    J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
    Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
    Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic role of SOX9 expression in human malignant glioma.
    Wang L; He S; Yuan J; Mao X; Cao Y; Zong J; Tu Y; Zhang Y
    Med Oncol; 2012 Dec; 29(5):3484-90. PubMed ID: 22714060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN reconstitution alters glioma responses to c-Met pathway inhibition.
    Goodwin CR; Lal B; Ho S; Woodard CL; Zhou X; Taeger A; Xia S; Laterra J
    Anticancer Drugs; 2011 Oct; 22(9):905-12. PubMed ID: 21654317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
    Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
    Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.
    Yang Y; Zhang C; Li L; Gao Y; Luo X; Zhang Y; Liu W; Fei Z
    World J Surg Oncol; 2012 Aug; 10():169. PubMed ID: 22913315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.
    Yamamoto S; Wakimoto H; Aoyagi M; Hirakawa K; Hamada H
    Jpn J Cancer Res; 1997 Jun; 88(6):564-77. PubMed ID: 9263534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
    Wang XB; Tian XY; Li Y; Li B; Li Z
    J Neurooncol; 2012 Jan; 106(1):43-51. PubMed ID: 21725855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
    Crosswell HE; Dasgupta A; Alvarado CS; Watt T; Christensen JG; De P; Durden DL; Findley HW
    BMC Cancer; 2009 Nov; 9():411. PubMed ID: 19939254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
    Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
    J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients.
    Xu HW; Huang YJ; Xie ZY; Lin L; Guo YC; Zhuang ZR; Lin XP; Zhou W; Li M; Huang HH; Wei XL; Man K; Zhang GJ
    BMC Cancer; 2013 May; 13():247. PubMed ID: 23688241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells.
    Yu W; Hu J; Le H; Lu Y; Xu W; Yu W; Shen W
    Pathol Res Pract; 2021 Jul; 223():153463. PubMed ID: 33971545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
    Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C; Luddy C; Abounader R; Lal B; Laterra J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma.
    Wang C; Fang M; Zhang M; Li W; Guan H; Sun Y; Xie S; Zhong X
    Neuropathology; 2013 Dec; 33(6):628-36. PubMed ID: 23714193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.